📰 Multiple System News
Page 2 - Multiple System News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multiple System. Real-time updates on events, politics, business and more.
February 20, 2024
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference – – Baseline Biomarker Data to be Presented from Ongoing ATH434-201...
February 20, 2024
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference –
January 22, 2024
– Preliminary Data from ATH434-202 Study Expected in 1H 2024 –– ATH434-201 Study to Complete in November 2024 – MELBOURNE, Australia and SAN...
January 22, 2024
– Preliminary Data from ATH434-202 Study Expected in 1H 2024 –– ATH434-201 Study to Complete in November 2024 – MELBOURNE, Australia and SAN FRANCISCO, Jan. 22, 2024 -- Alterity...
December 21, 2023
MELBOURNE, Australia and SAN FRANCISCO, Dec. 21, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...
December 4, 2023
- ATH434 improved motor performance and general function – - Webcast to be held this week to discuss new data and recent clinical progress – MELBOURNE, Australia and SAN FRANCISCO, Dec. 04,...
December 4, 2023
MELBOURNE, Australia and SAN FRANCISCO, Dec. 04, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, will...
November 27, 2023
May 16, 1956-Nov. 20, 2023 Leeds David Peder Sebelius, aged 67, of Leeds, peacefully transitioned to the eternal world on November 20, 2023, following a cou
November 27, 2023
MELBOURNE, Australia and SAN FRANCISCO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a...
November 27, 2023
MELBOURNE, Australia and SAN FRANCISCO, Nov. 27, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...